Real-World treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 4-year results from the PEDISTAD Registry

Alan D. Irvine, Trinity College Dublin, Dublin, Dublin, Ireland; Michele Ramien, Alberta Children's Hospital, Calgary, AB, Canada; Lin Ma, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, Beijing, China (People's Republic); Eulalia Baselga, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain; Marlies de Graaf, University Medical Center Utrecht, Utrecht, Utrecht, Netherlands; MARTTI A. ANTILA, Clinica de Alergia Martti Antila, Sorocaba, Sao Paulo, Brazil; Nelson A. Rosario Filho, UFPR, Curitiba, Parana, Brazil; Lara Wine Lee, Medical University of South Carolina, Charleston, SC, United States; Joel C. Joyce, Endeavor Health, Skokie, IL, United States; Rajan Gupta, Sanofi, Houston, TX, United States; Marius Ardeleanu, Regeneron, Tarrytown, NY, United States; Annie Zhang, Sanofi, Cambridge, MA, United States